Published TCIMAIL newest issue No.196
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 220127-57-1 | Product Number: I0936
Imatinib Mesylate
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- Imatinib Methanesulfonate
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 100MG |
£51.00
|
1 | ≥100 |
|
| 1G |
£323.00
|
1 | 34 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | I0936 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__9H__3__1N__7O·CH__4O__3S = 589.72 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 220127-57-1 |
| Related CAS RN | 152459-95-5 |
| Reaxys Registry Number | 24055984 |
| PubChem Substance ID | 253661958 |
| MDL Number | MFCD04307699 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 97.0 % |
| NMR | confirm to structure |
Properties (reference)
| Solubility (slightly sol. in) | Methanol |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
Related Laws:
| RTECS# | CV5520550 |
Transport Information:
| HS Number | 2933599590 |
Application
Imatinib Mesylate: A Tyrosine Kinase Inhibitor and a Molecular-Targeted Agent
Imatinib mesylate and Imatinib [I0906] are synthetic tyrosine (Tyr) kinase inhibitors and molecular-targeted agents that specifically target several protein tyrosine kinases, such as stem-cell factor receptor (c-KIT), platelet-derived growth factor receptor (PDGF-R), and notably Bcr-Abl. Imatinib mesylate is used in the treatment of chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies. (The product is for research purpose only.)
References
- Imatinib mesylate - a new oral targeted therapy (a review)
- Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug (a review)
- Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
- Imatinib: a review of its use in chronic myeloid leukaemia
- Imatinib mesylate (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.